Rocket Lab's defense contracts and backlog position it to benefit from national-security spending. Its $2.36B backlog includes over 100 booked launches, with an $816M SDA satellite deal and a $266M Space Force HASTE deal for hypersonic testing. Despite the Neutron delay, its $36B valuation offers one of the space sector's best risk-reward setups: exposure to the same defense and space-infrastructure trend as SpaceX at a fraction of its valuation. Rocket Lab is headed above $100. x.com 

Rocket Lab's growing Space Systems business positions it to provide more than launches for the space economy. It generated $189.5M in Q2, 81% of revenue; if its pending Iridium acquisition closes, it would gain a global satellite communications network. At about $51, this is one of the most compelling long-term opportunities in the space sector over 3-5 years, provided it keeps executing. Neutron's launch has slipped to 2027, and execution risks remain. x.com  x.com  x.com 

Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com  x.com  x.com  x.com 

Investors rotating into cheaper stocks with more upside should ultimately benefit Rocket Lab and AST SpaceMobile. Both have already suffered major drawdowns. x.com 

Rocket Lab is underestimated as a launch company when it is building a broader space infrastructure business, where satellites, components, spacecraft systems and national-security demand could matter as much as launches. It just signed its largest commercial Electron deal by mission count, 20 launches for Synspective from 2028 to 2031, per Wall St Engine, pushing its launch backlog above 100 missions. x.com 

Space and defense stocks such as Rocket Lab, Kratos and AeroVironment warrant skepticism after a big run because the sector doesn't generate profits the way other sectors do. Many of the announced deals are burdens that take a long time to execute. Excitement around Rocket Lab could return before or after its Neutron launch. x.com  x.com  x.com 

Rocket Lab keeps executing: the US Space Force awarded it a $397M contract to build multiple advanced Flatellite spacecraft for the SB-AMTI program, which detects and tracks airborne threats in real time, and to launch them on Neutron. x.com 

The real moat in space is cadence and capacity, not technical superiority. Proving something works is different from building and launching it reliably at scale, and Rocket Lab and SpaceX understand what it takes to scale. x.com 

Rocket Lab's price bets on the most optimistic version of its results a decade out while it is still losing money, so the market is pricing a story rather than the company. Narrative now earns a premium and earnings do not, as with IonQ and AI-server-labeled Dell and HPE, and one quarterly miss means exit. This can last a long time in liquid, risk-on markets, as 1999 dot-coms and 2021 SPACs showed, so a drop is not imminent; buyers now are buying how long sentiment lasts. x.com 

Rocket Lab is one of the very few public space companies with a real chance to compete alongside SpaceX, in a trillion-dollar space economy with room for several major winners as launch demand explodes. It posted a record quarter with a $2.2 billion backlog, won a $30 million Anduril contract, signed its largest launch agreement, was picked with Raytheon for the Space Force's Space-Based Interceptor program, and is acquiring Motiv Space Systems. x.com